What We Do
Our innovative thinking and strategic advice helps clients in the payer, provider, digital health, and life sciences sectors realize their most ambitious organizational and operational visions by bridging the gap between their business today and their vision for the future.
At Oliver Wyman, we are focused on creating positive change in healthcare, but we know we can’t do it all ourselves. Together, with today's leading healthcare experts and innovators, we’ve built a community to share and shape ideas that will transform healthcare. We work to ensure industry transformation through generating meaningful client impact, delivering strategic insights, and creating a healthcare system that meets the needs of communities and companies.
On November 1, 2021, the Huron life sciences strategy consulting team joined Oliver Wyman, allowing us to bring our relentless pursuit of a better way to pharmaceutical, biotechnology, and medical device companies. Our new colleagues bring the expertise needed to help life sciences companies tackle their most pressing strategic questions, including increasingly complex commercialization and access-related issues.
What We Think
Designing For 2035
Dive into the future of healthcare with industry leaders. Discover innovative strategies for designing a healthcare system for the next decade
Read MoreThe Impact Of Climate Change On Human Health
This new study projects as many as 14.5 million additional deaths and $12.5 trillion in economic losses by 2050
Read MoreLife sciences Dealmaking Poised To Rebound In 2024
Investors should be encouraged by the increased need for new revenue streams and heightened demand for inorganic growth strategies among biopharma companies
Read MoreEurope's Innovation Dilemma
Europe’s pharmaceutical industry risks falling behind the rest of the world without increased investment in innovation
Read MoreHow Pharma Can Achieve Net Zero Goals
Pharmaceutical companies are making bold pledges to reduce their carbon footprints. Getting there means overcoming some significant hurdles
Read MoreThe Case For Partnering With Your Competitors
From a potential recession to growing cost pressures, insurers face a host of uncertainties this year. One way to ease the pain is to take a cue from other industries and partner with competitors.
Read MoreSolutions
There is immense pressure across the entire healthcare landscape to provide higher quality care, improve the patient experience, lower costs, and reduce clinician burnout. Our Affordability and Quality Impact practice has deep expertise across lines of business to help organizations identify cost drivers, find efficiencies, improve quality of care, and more.
Who We Are
-
Deirdre Baggot Partner and Private Capital Leader
-
Andreas Eggert Partner and Europe Health and Life Sciences Leader
-
Martin Graf Partner and Government Services Leader
-
Minoo Javanmardian Partner and Provider Transformation Leader
-
Adeel Kheiri Partner
-
Ben Paik Partner and Americas Life Sciences Leader
-
Shivani Shah Executive Director and Health Innovation Center Leader
-
Sumit Sharma Partner and Head of Health and Life Sciences, IMEA
-
Terry Stone Managing Partner